Microbicide Trials Network Statement on the status of VOICE Study following announcement to close the FEM-PrEP trial

Researchers Reformulate Tenofovir Vaginal Gel for Rectal Use

Tenofovir Gel Provides High Level of Protection Against HIV in Rectal Tissue

Study comparing tenofovir gel and oral tablet finds gel provides more drug to tissue

Trial shows ARVs can prevent HIV in men who have sex with men, making VOICE Study in women more important than ever

Promising HIV prevention microbicide tenofovir gel in new trial testing safety of rectal use

Results of CAPRISA 004 a turning point for HIV prevention, say MTN researchers conducting VOICE

Phase I Study Finds Candidate Microbicide VivaGel Generally Well Tolerated but Women Less Willing to Use It

Researchers report results of first microbicide trial in pregnant women. Study indicates small amount of drug passes to fetus.

Microbicide Trials Network Statement on the Results of MDP 301